Adenosine phosphate

This classification denotes an aprt gene, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 415SHH325A. European Medicines Agency schedules Adenosine phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05267MIG. Adenosine phosphate generally arises in the molecular formula C10H14N5O7P. The term ADENOSINE PHOSPHATE is an International Non-Proprietary Name or INN. Most nations, for tariff and trade purposes, schedule adenosine phosphate under HS 29349990 and SITC 51579. As of Q4 2014, ADENOSINE PHOSPHATE remains US FDA's Preferred Term for this commodity. Adenosine phosphate bears US NLM identifiers UMLS ID C0001413 and NCI Concept Code C83606. SMILES: C1NC(C2C(N1)N(CN2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N.